{
    "nct_id": "NCT04332341",
    "official_title": "A Pilot Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation",
    "inclusion_criteria": "* All disease indications for allogeneic hematopoietic cell transplantation except for myelofibrosis.\n* Subject must meet program eligibility criteria* for myeloablative conditioning alloHCT and plan to undergo myeloablative conditioning.\n* HLA-identical related donor or unrelated human donor source with bone marrow graft.\n* Subjects must provide a written informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* History of allergy or intolerance to NR precursor compounds, including niacin or nicotinamide\n* Pregnant or breastfeeding women are excluded from this study since allogeneic HCT is a strict contraindication.\n* Subjects with uncontrolled intercurrent illness or psychiatric illness/social situations that would limit compliance with study requirements.",
    "miscellaneous_criteria": ""
}